immune system
N |
• normal lymphocyte development
• normal expression of CD3, B220, CD4, and CD8 in thymocytes and splenocytes
|
• impaired expression of CD69, CD80, and CD86 in response to poly(I:C), but not LPS
• impaired expression of CD69 in response to viral genomic dsRNA from Type I Lang mammalian reovirus
|
• impaired ability to produce IL6, IL12 and TNF-alpha in response to poly(I:C), a synthetic dsRNA analogue
• production of IL6, IL12, and TNF-alpha in response to LPS, PGN, LTA, zymosan, mannan, or CpG DNA was comparable to wild-type controls
|
• resistant to poly(I:C)-induced shock compared to wild-type mice
• produced less IL12 after poly(I:C) i.p. injection
|
behavior/neurological
• retain memory of platform location in Morris maze tests up to 120 hours compared to 72 hours in controls
|
• enhanced working memory
|
• in open field tests and elevated + mazes
|
• less cued fear response to a tone
|
• greater hippocampus dependent contextual fear response, freezing times
|
• increased interest in novel objects
|
• poorer rotarod performance and motor learning
|
nervous system
• increased hippocampal neurogenesis
|
• increased in volume
|
• increased in volume
|
cardiovascular system
• protective effect of poly I:C on neointimal formation is lost
|
homeostasis/metabolism
• protective effect of poly I:C on neointimal formation is lost
|
hematopoietic system
• impaired expression of CD69, CD80, and CD86 in response to poly(I:C), but not LPS
• impaired expression of CD69 in response to viral genomic dsRNA from Type I Lang mammalian reovirus
|
• impaired ability to produce IL6, IL12 and TNF-alpha in response to poly(I:C), a synthetic dsRNA analogue
• production of IL6, IL12, and TNF-alpha in response to LPS, PGN, LTA, zymosan, mannan, or CpG DNA was comparable to wild-type controls
|